Apply knowledge of recent clinical data together with current expert recommendations to patient selection for new and emerging therapies for advanced breast cancer
Apply knowledge in the treatment of breast cancer in special populations (including the elderly and young women) and adjust treatment decisions for specific patients as needed
Select appropriate risk assessment modalities, where applicable and make evidence-based therapeutic selections for women who are candidates for neoadjuvant or adjuvant therapy and know the limitations of genomic testing
Apply recent clinical data and expert recommendations to the management of women with breast cancer who are treated with mastectomy, including integration of surgical methods, breast reconstruction options and post-mastectomy radiation if needed
Assess current practices with regard to symptom management during active treatment and in survivorship and consider the needs for fertility and lifestyle counseling among patients with breast cancer and survivors and improve current practices if needed
Evaluate the genetic and personal risk factors of breast cancer and utilize appropriate genetic testing for hereditary breast cancer
Breast Cancer: New Horizons, Current Controversies is a comprehensive educational curriculum that encompasses the full range of breast cancer care. Topics include mechanisms of disease, improvements in diagnostic methods, treatment innovations and management of breast cancer survivors. The primary goal of the course is to improve the knowledge, competence and clinical skills of health care professionals who specialize in oncology. As such, the curriculum is well suited for medical, surgical, and radiation oncologists; breast and general surgeons; internists; physician assistants; nurse practitioners; oncology nurses and other clinicians involved in the care of breast cancer patients.
The three-day course is taught by clinical experts in medical, surgical and radiation oncology. Each year, the course faculty identify emerging practice gaps in breast oncology and address those gaps by translating the latest scientific knowledge into practical clinical applications. Course participants engage with the material through interactive learning formats, including group case discussions, question and answer sessions, and panel presentations. This interactive learning process assists healthcare professionals in integrating the latest evidence-based information on breast cancer screening, diagnosis, treatment and long-term monitoring into their clinical practices.
This is an accredited, livestreamed course offered by Dana Farber Cancer Institute, Brigham and Women's Hospital and Massachusetts General Hospital. This course is targeted to Primary Care Physicians, Specialty Physicians, Nurses, Nurse Practitioners,and Physician Assistants. This course may also be of interest to physicians who practice in Oncology and Hematology, Plastic Surgery, Surgery, Internal Medicine, Genetics and Family Medicine.
Select the Take Course button to view additional information on the course registration page.
Contact ceprograms@hms.harvard.edu with questions.
*Register before June 8 to receive the discounted price.
